1. Badrinath P, Gupta A. Have we abandoned the Inglefinger rule in the COVID era? [electronic response to Wise J. Data transparency: “Nothing has changed since Tamiflu”]. BMJ 2020. https://www.bmj.com/content/369/bmj.m2279/rr-1.
2. Covid-19: Molnupiravir reduces risk of hospital admission or death by 50% in patients at risk, MSD reports
3. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis
4. β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells
5. Krauskopf L, Maddipatla M. Merck COVID-19 pill success slams Moderna shares, shakes up healthcare sector. https://www.reuters.com/business/healthcare-pharmaceuticals/merck-covid-19-pill-success-slams-moderna-shares-shakes-up-healthcare-sector-2021-10-01/